Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 44619

AbstractConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Reviews
Year : 2021 | Month : August | Volume : 15 | Issue : 8 | Page : OE01 - OE07 Full Version

Prevention of SARS-CoV-2 Infection with Antioxidants and Anti-inflammatory Action of Indian Spices: Light at the End of the Tunnel


Published: August 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/49530.15245
Sandeep Negi, Sonal Bhatt, Lakshmi Bala

1. Research Scholar, Department of Biochemistry, Babu Banarasi Das University, Lucknow, Uttar Pradesh, India. 2. Research Scholar, Department of Nutrition, Babu Banarasi Das University, Lucknow, Uttar Pradesh, India. 3. Professor, Department of Biochemistry, Babu Banarasi Das University, Lucknow, Uttar Pradesh, India.

Correspondence Address :
Dr. Lakshmi Bala,
Professor, Department of Biochemistry, Babu Banarsi Das University,
Lucknow-201206, Uttar Pradesh, India.
E-mail: lakshmi266@gmail.com

Abstract

Today, we are living in the era of Coronavirus Disease-2019 (COVID-19), a pandemic that has affected almost the whole globe. It has rightly been called as the ‘twenty-first-century plague’ which has garnered considerable attention from researchers, pharma companies, policymakers, and media. Though vaccines are being deployed and people are eagerly receiving vaccination; the duration of conferred immunity, the possibility of re-infection of recovered/vaccinated individuals, the consequence of the new mutation in SARS-CoV-2 and its impact and challenge for the efficacy and degree of protection that a potential vaccine could provide is under question. In the absence of any definite answer, people are turning towards natural remedies and spices. India is known globally as the land of spices. Spices like ginger, garlic, black pepper, cardamom, turmeric, clove, cinnamon, etc., are known for their rich aroma, texture, and immunity boosting ingredients. These are rich sources of antioxidants such as flavonoids and alkaloids. The antioxidants present in them, neutralise the free radicals generated inside the body during viral infections and also prevent cellular damage. These exhibit anti-inflammatory activity and have the potential to combat “cytokine storm” in severe COVID-19 infection. Their potential has been realised by the public and has led to a tremendous increase in global demand and consumption. The present review enlists the active ingredients present in important spices and addresses their antioxidants, anti-inflammatory, and anti-viral action. Traditional Indian spices that are not only a cardinal part of the diet but are affordable, easily available can be viewed as the light at the end of the tunnel to combat the current COVID-19 conditions as a preventive measure.

Keywords

Clove, Curcumin, Cytokine storm, Garlic, Ginger, Severe acute respiratory syndrome coronavirus 2

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) which is responsible for the global cause of Coronavirus Disease-2019 (COVID-19) has the property to constantly change itself through mutation. Today, with the help of genetic analysis it is possible to identify multiple variants of SARS-CoV-2. Most of the mutations are harmless while some result in forms that spread more quickly, cause more serious illness, or resist drugs. World Health Organisation (WHO) has given Greek alphabet naming scheme for such “variants of concern” and “variants of interest”. These different variants of viruses identified so far are:

1. UK variant (B.1.1.7 or ‘Kent Variant’ is referred to as “alpha”), detected in December 2020;
2. South Africa variant (B.1.351 or “beta”), also detected in December 2020;
3. Brazil variant (P.1 or “gamma”), identified by January 2021;
4. Two more variants (B.1.427 and B.1.429) were first identified in California in February 2021 (1);
5. Another highly transmissible variant (B.1.617) responsible for the second covid wave in India during April 2021 with notable triple-variant (B.1617.1or “kappa” and B.1.617.2 or “delta”) (2). These different variants rendered the virus more transmissible posing greater public health risks.

Presently, there are no proven effective therapies for COVID-19 to prevent infection or stop transmission of disease. Within a month of the onset of the pandemic, the United States (US) Food and Drug Administration (FDA) issued an emergency use authorisation for the use of repurposed approved drugs such as hydroxychloroquine, chloroquine (antimalarial drug), ritonavir, and lopinavir (a combination of antiretroviral drugs), remdesivir (an experimental Ebola drug) and steroids, interferon-beta, several immunomodulators, and anti-inflammatory drugs for the treatment of hospitalised patients with COVID-19. This lead to a surge in clinical trials of many approved drugs and the development of effective vaccines. The efficacy of different vaccines was reported to be different as per clinical trials:

1. Pfizer (91% against B.1.1.7);
2. Moderna (94% against B.1.1.7);
3. Oxford AstraZeneca (74% against B.1.1.7);
4. Johnson and Johnson (Janssen) (72% against B.1.1.7; 64% against B.1.351, P.1 and B.1.617);
5. Sputnik-V (92% against B.1.1.7);
6. Covaxin- India’s 1st COVID-19 vaccine (78% against B.1.1.7) (3),(4).

Several vaccines are deployed worldwide to ensure fair and equitable vaccination of mass for prevention of disease along with other safety measures as hand sanitisation, wearing of masks, and social distancing to combat this pandemic. However, many questions still remain unanswered about the real safety and efficacy of vaccines, the possibility of re-infection of recovered/vaccinated individuals, the duration of conferred immunity, the consequence of the new mutation in SARS-CoV-2, and its impact and challenge for the efficacy and degree of protection that a potential vaccine could provide. It has been observed that an individual’s immunity plays an important role in combating infection of SARS-CoV-2 by reducing its pathogenic capacity within the host (5).

The SARS-CoV-2 infection starts with its entry into host epithelial cells (lungs, intestine, etc.) via binding of its S (spike) protein with Angiotensin-Converting Enzyme 2 (ACE 2) receptor of host cells. Some of the active ingredients (andrographolide, berberine, curcumin, mangiferin, nimbin, piperine, thebaine, gallic acid, luteolin, naringenin, quercetin, resveratrol, and zingiberene and withaferin A, etc.) present in spices turmeric, garlic, pepper, cinnamon, etc., have been shown to have binding affinity for either the ACE2 receptor or SARS-CoV-2 S protein or both. These compounds might inhibit the attachment of the SARS-CoV-2 virus to the host cell (6) (Table/Fig 1), (Table/Fig 2), (Table/Fig 3). Further, the entry of the virus inside the cell generates a high amount of free radicals (e.g., superoxide anion radical, hydroxyl radical, singlet oxygen, hydrogen peroxide, peroxynitrite radical, hypochlorite, and nitric oxide radical). These are highly reactive and are capable of destroying biologically essential molecules in the nucleus and membranes of cells, such as DNA, proteins, carbohydrates, and lipid (7),(8),(9). The natural antioxidants present in the body e.g., glutathione, vitamin C and E, superoxide dismutase, CYP etc., can donate an electron to a free radical and neutralise it, thus reducing or preventing its destructive potential of cellular damage (10),(11). With the enormous generation of free radicals, the natural antioxidants fall short and leads to oxidative stress. The miraculous treasure of various antioxidants present in spices prevents the cell from oxidative stress and serves as an immunity booster (10). When a virus enters the host cell cytoplasm, it takes over the host’s protein-synthesising machinery and translates its mRNA in the nucleus for the production of viral proteins. This promotes viral replication and the formation of mature viruses and their release. This leads to activation of cells of the immune system like macrophages, monocytes, and agranulocytes triggering the release of various types of chemokines, interferons, interleukins (IL-2, IL-6, IL-8, IL-10, IL-2R, IL-7, etc), colony-stimulating factors, and Tumour Necrosis Factor-α (TNF-α) (8),(9). The condition of hyperactive pro-inflammatory immune response is called “cytokine storm”. This condition is responsible for the high degree of damages to host cells depending upon the severity and progress of viral infection. It also leads to life-threatening conditions like Acute Respiratory Distress Syndrome (ARDS), multiple organ failure, etc., and finally death of the patient. Congregated evidence for the anti-inflammatory action of spices in various pre-clinical and clinical studies is documented that may help in preventing cytokine storm (12). Quercitin, lycorine, myricetin, caffeic acid, scutellarein, silvestrol, and tryptanthrin etc., have also shown antiviral activities in general (13).

Efforts to carry out clinical trials in the more organised way should come in the forefront for developing Indian spices as an efficient and cheap preventive and treatment option against the devastating pandemic. This review addresses the important constituents present in the Indian spices which are anti-oxidant, anti-inflammatory, immunomodulatory, and may protect from ‘cytokine storm’ to act as an effective weapon for prevention of COVID-19.

SPICES THAT BOOST IMMUNITY AGAINST COVID-19

Ginger (Zingiber officinale)

It is well known and belongs to the family Zingiberaceae. It not only adds flavour and taste to the food but also has a wide range of medicinal properties. Since ancient times, ginger tea or ginger extract has been commonly used to treat common colds, flu, and sore throats (17). Gingerol is an antioxidant that strengthens our immune system, has antiviral effects, and aids in the treatment of respiratory problems. It has recently been shown to be beneficial for COVID-19 patients (18), as it binds to many target virus proteins and decreases pathogenicity, according to Rathinavel T et al., (2020) (19). Important enzymes such as alliinase, peroxidase, and myrosinase are also present. Allicin, alliin, and ajoene are sulfur-rich compounds that are among the main ingredients. It is an effective antioxidant agent since it includes compounds like superoxide dismutase and glutathione peroxidase, which play a key role in the body’s defense mechanism against viral infections (20). It has anti-inflammatory effects, functions as an analgesic, decreases blood cholesterol levels, and is helpful to people with heart disease.

Ginger hot water extract is very effective against the Respiratory Syncytial Virus (RSV), avian influenza, norovirus, and Feline calicivirus in studies (FCV). It stops viral plaques from forming in the airway epithelium cells and blocks viral attachment sites (21). The aqueous ginger extract, garlic, and other herbs protect the food from contamination (22).

Garlic (Allium sativum)

Garlic also has a wide spectrum of pharmacological effects, including cardioprotective, antioxidant, anti-inflammatory, anti-viral, anti-cancerous, and immunomodulatory properties, in addition to its food additive quality. Garlic, belongs to the family Amaryllidaceae, has been used as a medicinal herb in Ayurvedic medicine for antimicrobial and antiparasitic purposes since ancient times. A variety of sulfur compounds are present which are the natural odour of garlic, the main one being allicin (diallyl thiosulfinate) (23). Allicin has been shown to play a role in the formation of T-cells and B-cells (24); it also stimulates the immune system’s CD8+ cells and T lymphocyte cells (25) against a variety of viral infections, including influenza A and B, Human Immunodeficiency Virus (HIV), Herpes Simplex Virus-1 (HSV-1), viral pneumonia, and rhinovirus (26). Garlic has been shown to have immunomodulatory effects by regulating the levels of cytokines and chemokines in the body (27), suggesting that it may be a promising candidate for countering the cytokine storm triggered by COVID-19. Garlic contains fructooligosaccharides, which are essential for immunomodulation. Its extract is thought to be anti-inflammatory, anti-atherosclerotic, and blood pressure-controlling (28).

Blackpepper (Piper nigrum)

Black pepper is commonly known as Kali Mirch in India. Also, popular as ‘spice king’ which increases the texture and aroma of food as a spice. In Ayurveda, it can also be prescribed for bronchopulmonary conditions, fever, neurological disorders, and gastrointestinal problems (29). Antioxidant, anti-viral, anti-inflammatory, anti-mutagenic, anti-parasitic, anti-bacterial, anti-asthmatic, anti-carcinogenic, anti-diarrhoeal, anti-ulcer, anti-thyroid, anti-apoptotic, anti-bacterial, anti-depressant, and immunomodulatory effects are some of its properties. It further enhances the therapeutic efficacy of various drugs, vaccines, and dietary supplements (30),(31),(32),(33). Piperine is a key component of black pepper that regulates the development of cytokines in various types of immune cells, including Th1, Th2, Th17, and Treg cells. It can also minimise inflammatory cell aggregation by preventing the expression of GATA3, IL-4, IL-6, IL-1, ROR, IL-17 A, and TNF in bronchoalveolar lavage fluid and increasing INF- and IL-10 secretion. It also promotes the growth of T and B cells, as well as macrophage cells (31),(34),(35). Piperine is also harmful to cells. It reduces histamine release and serum immunoglobulin E, anti-OVA IgE, anti-OVA IgE1, and anti-OVA IgE1. It induces necrosis and inflammatory cell invasion. It also inhibits Th2/Th17 responses and activates mast cells. It inhibits NF-kB, c-Fos, the cAMP response bound element, and factor-2 transcription. It inhibits PKCa/Extracellular signal-Regulated Kinase (ERK) 1/2 and decreases NF-kB/AP-1 activation, as well as PMA-mediated MMP-9 expression. It’s also in control of p-glycoprotein inhibition and the CYP3A44 feature (36),(37),(38),(37).

Cardamom (Elettaria cardamomum)

Cardamoms are dried fruit capsules of the Zingiberaceae family. Its capsules are used to manage cataracts, nausea, gum infections, teeth and gastrointestinal, kidney diseases, asthma, diarrhoea, cardiac problems, for culinary and alternative medicine applications (38).

Antioxidant properties: Cardamom seeds are the storage of large-quality antioxidants, which scavenge free radicals by preventing the oxidation of other materials. Cardamom, according to Nair S et al., has a moderate degree of natural antioxidant properties due to the existence of phenol compounds such as quercetin, kaempferol, and luteolins (39). Natural antioxidants are considered to be safer than synthetic antioxidants (40). The essential oils in cardamom, including phytonutrients and vitamins, serve as antioxidants, scavenging free radicals and preventing cellular aging (40),(41).

Antimicrobial properties: Cardamom’s essential oil has powerful antimicrobial properties against various food microorganisms (42). The growth of Morgenella morganii was significant inhibited by the use of cardamom oil. Antimicrobial effect was also shown by essential oil extracted from cardamon towards Staphylococcus aureus, Escherichia coli, Streptococcus mutans, Salmonella typhi, Candida albicans, Bacillus pulmilus and Listeria monocytogenes (43). Most research focusing on the antibacterial activity of cardamom extracts and their essential oil was performed using the method of disc diffusion (44).

Turmeric (Curcuma longa)

In India, it is popularly called “Haldi”. The active ingredient is a polyphenolic compound known as curcumin, which acts as anti-inflammatory, anti-microbial, and has an immunomodulatory impact on our body (45). It prevents the entry of viruses into the cell, inhibits the encapsulation of viruses and virus proteases, and modulates many cellular signaling pathways (46). It is also effective in the therapy of osteoarthritis and rheumatoid arthritis. Turmeric has been suggested as a useful treatment of choice against COVID-19 (47). The following are the primary effects of curcumin on respiratory disorders.

Curcumin’s effect on pulmonary inflammation: In the inhibition of inflammatory cytokines, curcumin has its key task. Its presence stops essential signals that regulate the expression of various pro-inflammatory cytokine pathways, such as nuclear factor B and MAPKK. It has anti-inflammatory and anti-fibrotic effects. This decreases the expression of chemokines and cytokines that are involved in lung infection, such as INFγ, MCP-1, IL-6, IL-10 (48),(49). It shows inhibitory effects against RSV infection by preventing viral replication, releasing TNF alpha, and down-controlling phosphor-NF-alpha-B (45),(46).

Curcumin’s effect on pulmonary fibrosis: Pathways mediated by the p38MAPK route for curcumin inhibit apoptosis (48).

Curcumin’s impact on pulmonary oedema: The disorder where fluid accumulation takes place in the lungs is pulmonary oedema. In recent research related to SARS-CoV-2 infection has shown that its protein envelope stimulates protein kinase C, thus reducing the function of pulmonary epithelial sodium channels contributing to pulmonary oedema (50). A study by Tian S et al., has shown that the use of curcumin reduces inflammation, leading to a decrease in the influx of fluid in the lungs of the rat (51).

Impact of curcumin on heart problems associated with COVID-19: The binding of the SARS-CoV-2 virus spike protein to the ACE2 respiratory epithelium cell receptor causes respiratory problems. In people with heart issues, these complications are more pronounced. The theory may be that AEC2 in cardio patients is more frequently expressed (52). Curcumin prevents myocardial ischemia-reperfusion damage by reducing c-Jun N-terminal kinase and NF-B nuclear translocation phosphorylation. It also decreases immune cell penetration and the expression of binding molecules and pro-inflammatory mediators in vascular cells (53).

The impact of curcumin on kidney diseases: In COVID-19, the incidence of acute kidney injury is often manifested in patients with co-morbidities. The high incidence may be due to the high expression of ACE2 in the kidneys in patients with diabetes (54) and may be the reason for renal damage. In rat models, curcumin up-regulates AEC2 and ACE2 mRNA that contributes to increased blood flow in the kidneys (55). By reducing inflammation caused by MCP-1, NF- κB, TNF, IL-1β, COX-2, and COX-1, at the stage of priming and activation, curcumin also decreases renal fibrosis. This lowers anti-inflammatory variables as well. It targets MAPK/ERK, TGF-β/smads, and PPAR-pathways in animal models (56).

Clove (Syzygium aromaticum)

It is a dried flower bud, commonly used because of its strong taste and aroma to prepare spicy recipes. Also, eugenol, a bioactive compound present in cloves has been documented to have a broad range of medicinal properties such as analgesic, anti-inflammatory, immunomodulatory and better remedy for respiratory disorders as one of their phytoconstituents (57). Furthermore, clove also has an important antiviral and antipyretic potency.

Cinnamon (Cinnamomum verum)

It is a medicinal plant commonly known as Dalchini. It is used for fever, oedema, cough, and indigestion as a natural immunity booster (58). Besides, due to its volatile bioactive components, cinnamon, the world’s frequently consumed spice, has also been reported to have essential antioxidant, antitumour, and anti-inflammatory potency (59). Cinnamaldehyde, cuminaldehyde, and eugenol are its major chemical constituents. Its bark consists of various beneficial compounds such as benzaldehyde, cinnamaldehyde, terpenes, and cuminaldehyde (60). By increasing immunoglobulin and phagocytic index levels, it enhances immunity, i.e., cell-mediated and humoral immunity (58). It is documented as a cell-mediated immunity regulator because of its NF-kB obstruction property that activates signaling components, PDK1 and NF-kB (35), CD29 and CD43 are also activated by cinnamon, which prevents cell migration and triggers the attachment of one cell to another cell. It decreases nitric oxide production and also regulates CD80 and CD69 levels and specific receptors such as TLR2 and CR3 that assist in pattern recognition. Cinnamon bark extract reduces the amount of IFN-alpha without affecting the level of IL-4 or IL-2. It also inhibits anti-CD3 antibodies induced by IFN-alpha and IL-4 at mRNA and secreted protein levels increase the secretion of IL2 protein at the cellular level, helping to reduce cell death. It inhibits IL-2 mRNA expression, inhibits anti-CD3 activation mediated by p38, JNK, ERK1/2, and STAT4, but does not degrade 1k B or STAT6 (49). This shows the inhibitory effects of cinnamon on cytokine secretion and its role in the signaling molecules of activated T cells. It also leads to a decrease in the process of subG1 and increases the necrotic to apoptotic cell ratio. Its constituents cinnamaldehyde and cinnamophilinhave thromboxane A2, the receptor antagonist. It is anticoagulative and anti-atherosclerotic, preventing unwanted clumping of platelets [61]. SARS-CoV-2 inhibitors from Cinnamon have recently been identified through in silico studies [62].

Star Anise (Illicium verum)

Star anise best known as Chinese star anise, is an aromatic member of the family Schisandraceae. It is of star shape, often reported to have numerous therapeutic applications because of its bioactive compounds, is commonly used as a culinary ingredient. It is one of the essential components of Chinese herbs and is well known for its antiviral effects. As an effective booster of immunity, it helps the body to fight many viral diseases. It is also the source of shikimic acid, the key molecule used in the manufacturing of oseltamivir (Tamiflu®), an antiviral drug for influenza A and influenza B. It has a wide range of other potentials properties in addition to its antiviral properties, such as antioxidant, antimicrobial, antifungal, etc. It is commonly used as a treatment in cough, asthma, dysentery, and in arthritis [63].

Nutmeg (Myristica fragrans)

Because of its mysterious sweet and spicy taste, Myristica fragrans has been one of the key constituents in Indian cuisine since ancient times and has also been reported to have important medical values. Nutmeg is used as a pain reliever because it has myristcine, myrcene, safrol, camphene, sabinene, linalool, 1,8-cineole, and eugenol as its volatile constituent, and it also has properties to treat stomach disease, respiratory disorders, heart disease, as well as a brain tonic, liver tonic and immunity booster [64].

Conclusion

Nutrition plays a key role in maintaining good health. Spices when added to our food items in a suitable amount, provide taste as well as act as a source of antioxidants to our body to protect from attack of harmful microorganisms. They interfere to different inflammatory factors like cytokines, growth factors (TNF- α interleukin), COX, lipoxygenase, and NOX in the NF-κB pathway.

In ancient and modern India, these spices were commonly used to treat many diseases. Many Indian spices having above mentioned active ingredients have tremendous potential as an immune booster, antioxidants, and anti-inflammatory agents in preventing/alleviating SARS-CoV-2 infection.

References

1.
https://www.cdc.gov/coronavirus/2019-ncov/variants/variant.html. Accessed on 30th May 2021.
2.
https://www.cnbc.com/2021/05/10/who-classifies-triple-mutant-covid-variant-from-india-as-global-health-risk-.html. Accessed on 30th May 2021.
3.
Skowronski DM, De Serres G. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. Letter. N Engl J Med. 2021;384(16):1576-77. Doi: 10.1056/NEJMc2036242. [crossref]
4.
http://www.healthdata.org/covid/covid-19-vaccine-efficacy-summary. Accessed May 30, 2021.
5.
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, et al. Immune-mediated approaches against COVID-19. Nat Nanotechnol. 2020;15(8):630-45. [crossref] [PubMed]
6.
Maurya VK, Kumar S, Prasad AK, Bhatt MLB, Saxena SK. Structure-based drugdesigning for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor r. Virus Disease. 2020;31:179-93. [crossref] [PubMed]
7.
Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4(8):118. [crossref] [PubMed]
8.
Is Y, Woodside JV. Antioxidant in health and disease. J Clin Pathol. 2001;54(3):176-86. [crossref] [PubMed]
9.
Bagchi K, Puri S. Free radicals and antioxidants in health and disease. East Mediterranean Health J.1998;4:350-60. [crossref]
10.
Liu T, Stern A, Roberts LJ. The isoprostanes: Novel prostanglandin-like products of the free radical catalyzed peroxidation of arachidonic acid. J Biomed Sci 1999;6:226-35. [crossref] [PubMed]
11.
Halliwell B. The antioxidant paradox. Lancet. 2000; 355, 1179-1180. [crossref]
12.
Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, et al. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci. 2021;284:119201. [crossref] [PubMed]
13.
Mani JS, Johnson JB, Steel JC, Broszczak DA, Neilsen PM, Walsh KB, et al. Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res. 2020;284:197989. Doi: 10.1016/j.virusres.2020.197989. [crossref] [PubMed]
14.
Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, et al. Chronic diseases, inflammation, and spices: How are they linked? J Transl Med. 2018;16(1):01-25. [crossref] [PubMed]
15.
Elengoe A. Indian spices boost the immune system against COVID-19. The Annals of the University Dunarea de Jos of Galati. Fascicle VI-Food Tech. 2020;44(2):189-206. [crossref]
16.
Mrityunjaya M, Pavithra V, Neelam R, Janhavi P, Halami PM, Ravindra PV. Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front Immunol. 2020;11:570122. [crossref] [PubMed]
17.
Chang JS, Wang KC, Yeh CF, Shieh DE, Chiang LC. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J Ethnopharmacol. 2013;145(1):146-51. Doi: 10.1016/j.jep.2012.10.043. [crossref] [PubMed]
18.
Safa O, Hassaniazad M, Farashahinejad M, Davoodian P, Dadvand H, Hassanipour S, et al. Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21(1):841. Doi: 10.1186/s13063-020-04765-6. [crossref] [PubMed]
19.
Rathinavel T, Palanisamy M, Palanisamy S, Subramanian A, Thangaswamy S. Phytochemical 6-Gingerol-A promising Drug of choice for COVID-19. Int J Adv Sci Eng. 2020;6(4):1482-89. [crossref]
20.
Sharma L. Indian Spices: Hidden Treasure to manage Ailments. EPRA International Journal of Multidisciplinary Research. 2017;3(3):226-30.
21.
Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim YT, et al.
22.
-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene. 2005;24(15):2558-67. Doi: 10.1038/sj.onc.1208446. [crossref] [PubMed]
23.
Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathulla AS, Kaur P. Identification of bioactive molecule from Withaniasomnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J Biomol Struct Dyn. 2020;01-14. Doi: 10.1080/07391102.2020.1790425. [crossref] [PubMed]
24.
Gruhlke MC, Nicco C, Batteux F, Slusarenko AJ. The Effects of Allicin, a Reactive Sulfur Species from Garlic, on a Selection of Mammalian Cell Lines. Antioxidants (Basel). 2017;6(1):01-16. Doi: 10.3390/antiox6010001. [crossref] [PubMed]
25.
Salman H, Bergman M, Bessler H, Punsky I, Djaldetti M. Effect of a garlic derivative (alliin) on peripheral blood cell immune responses. Int J Immunopharmacol. 1999;21(9):589-97. Doi: 10.1016/s0192-0561(99)00038. [crossref]
26.
Reinhart KM, Talati R, White CM, Coleman CI. The impact of garlic on lipid parameters: A systematic review and meta-analysis. Nutr Res Rev. 2009;22(1):39-48. Doi: 10.1017/s0954422409350003. [crossref] [PubMed]
27.
Sawai T, Itoh Y, Ozaki H, Isoda N, Okamoto K, Kashima Y, et al. Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin. Immunology. 2008;124(2):155-65. [crossref] [PubMed]
28.
Donma MM, Donma O. The effects of allium sativum on immunity within the scope of COVID-19 infection. Med Hypotheses. 2020;144:109934. Doi: 10.1016/j.mehy.2020.109934. [crossref] [PubMed]
29.
Arreola R, Quintero-Fabián S, López-Roa RI, Flores-Gutiérrez EO, Reyes-Grajeda JP, Carrera-Quintanar L, et al. Immunomodulation and anti-inflammatory effects of garlic compounds. J Immunol Res. 2015;3(4):401630. Doi: 10.1155/2015/401630. [crossref] [PubMed]
30.
Stojanovic-Radic Z, Pejcic M, Dimitrijevic M, Aleksic A, V Anil Kumar N, Salehi B, et al. Piperine-A major principle of black pepper: A review of its bioactivity and studies. Applied Sciences. 2019;9:01-29. [crossref]
31.
Nahak G, Sahu RK. Phytochemical evaluation and antioxidant activity of Piper cubeba and Piper nigrum. J Appl Pharm Sci. 2011;1:153-57.
32.
Damanhouri ZA. A review on therapeutic potential of Piper nigrum L. (Black Pepper): The king of spices. J Med Aromat Plants. 2014. https://doi.org/ 10.4172/2167-0412.1000161. [crossref]
33.
Srivastava AK, Singh VK. Biological action of Piper nigrum e the king of spices. Eur J Cell Biol. 2017. https://doi.org/10.5281/zenodo.839039. [crossref] [PubMed]
34.
Peterson CT, Rodionov DA, Iablokov SN, Pung MA, Chopra D, Mills PJ, et al. Prebiotic potential of culinary spices used to support digestion and bioabsorption. Evidence-Based Complementary and Alternative Medicine. 2019;8973704.
35.
Balkrishna A, Solleti SK, Singh H, Tomer M, Sharma N, Varshney A. Calcioherbal formulation, Divya-Swasari-Ras, alleviates chronic inflammation and suppresses airway remodelling in mouse model of allergic asthma by modulating pro-inflammatory cytokine response. Biomed. Pharmacother. 2020. https://doi.org/10.1016/j.biopha.2020.110063. [crossref] [PubMed]
36.
Gautam S, Gautam A, Chhetri S, Bhattarai U. Immunity against COVID-19: Potential role of Ayush Kwath. J Ayurveda Integr Med. 2020. https://doi.org/10.1016/j.jaim.2020.08.003. [crossref] [PubMed]
37.
Zhai WJ, Zhang ZB, Xu NN, Guo YF, Qiu C, Li CY, et al. Piperine plays an anti-inflammatory role in Staphylococcus aureus endometritis by inhibiting activation of NF-kB and MAPK pathways in mice. Evid Compl Altern Med. 2016;8597208. https://doi.org/10.1155/2016/8597208. [crossref] [PubMed]
38.
Bui TT, Piao CH, Hyeon E, Fan Y, Van Nguyen T, Jung SY, et al. The protective role of Piper nigrum fruit extract in an ovalbumin-induced allergic rhinitis by targeting of NFkBp65 and STAT3 signalings. Biomed. Pharmacother. 2019;109:1915-23. https://doi.org/10.1016/J.BIOPHA.2018.11.073. [crossref] [PubMed]
39.
Khan AU, Khan QJ, Gilani AH. Pharmacological basis for the medicinal use of cardamom in asthma. Bangl J Pharmacol. 2011;6(1):34-37. [crossref]
40.
Nair S, Nagar R, Gupta R. Antioxidant phenolics and flavonoids in common Indian foods. J Assoc Physicians India. 1998;46(8):708-10.
41.
Saeed A, Sultana B, Anwar F, Mushtaq M, Alkharfy KM, Gilani AH. Antioxidant and antimutagenic potential of seeds and pods of green cardamom (Elettaria cardamomum). Int J Pharm. 2014;10(8):461-69. [crossref]
42.
Ashokkumar K, Murugan M, Dhanya MK, Warkentin TD. Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton]-A critical review. J Ethnopharmacol. 2020;10:01-40. [crossref] [PubMed]
43.
Kubo I, Himejima M, Murari H. Antimicrobial activity of flavour components of Cardamom. J Agric Food Chem. 1991;39:1984-86. [crossref]
44.
Bano S, Ahmad N, Sharma AK. Phytochemical screening and evaluation of anti-microbial and anti-oxidant activity of Elettaria cardamom (Cardamom). J Applied Natural Sci. 2016;8(4):1966-70. [crossref]
45.
Gradinaru AC, Aprotosoaie AC, Trifan A, Spac A, Brebu M, Miron A. Interactions between cardamom essential oil and conventional antibiotics against Staphylococcus aureus clinical isolates. Farmacia. 2014;62(6):1214-22.
46.
Zahedipour F, Hosseini SA, Sathyapalan T, Majeed M, Jamialahmadi T, Al-Rasadi K, et al. Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res. 2020;01-10. https://doi.org/10.1002/ptr.6738. [crossref] [PubMed]
47.
Gupta H, Gupta M, Bhargava S. Potential use of Turmeric in COVID-19. Clin Exp Dermatol. 2020;45(7):902-03. Doi: 10.1111/ced.14357. [crossref] [PubMed]
48.
Emirik M. Potential therapeutic effect of turmeric contents against SARS-CoV-2 compared with experimental COVID-19 therapies: In silico study. J Biomol. 2020;01-14. Doi: 10.1080/07391102.2020.1835719. [crossref] [PubMed]
49.
Avasarala S, Zhang F, Liu G, Wang R, London SD, London L. Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome. PLoSONE. 2013. https://doi.org/10.1371/journal.pone.0057285. [crossref] [PubMed]
50.
Negi S, Bala L. Natural home remedies may act as Immunomodulators to protect against SARS-CoV-2 infection. J Exp Biol. 2020;8(Spl-1-SARS-CoV-2).S176-S189. http://dx.doi.org/10.18006/2020.8. [crossref]
52.
DeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, Regla-Nava JA, Castaño-Rodriguez C, Fernandez-Delgado R, et al. Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Research. 2014. https://doi.org/10.1016/j.virusres.2014.07.024. [crossref] [PubMed]
52.
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700-04. https://doi.org/10.1016/j.jtho.2020.02.010. [crossref] [PubMed]
53.
Zheng Y. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020;17:259-60. https://doi.org/10.1038/s41569-020-0360-5. [crossref] [PubMed]
54.
Li X, Fang Q, Tian X, Wang X, Ao Q, Hou W, Bai S. Curcumin attenuates the development of thoracic aortic aneurysm by inhibiting VEGF expression and inflammation. Mol Med Rep. 2017;16(4):4455-62. https://doi.org/10.3892/mmr. 2017.7169. [crossref]
55.
Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: Implications for albuminuria in diabetes. J Am Soc Nephrol. 2006. https://doi.org/10.1681/ASN.2006050423. [crossref] [PubMed]
56.
Xu X, Cai Y, Yu Y. Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats. Inflammo pharmacology. 2018. https://doi.org/10.1007/s10787-018-0449-1. [crossref] [PubMed]
57.
Sun X, Liu Y, Li C, Wang X, Zhu R, Liu C, Li Y. Recent advances of curcumin in the prevention and treatment of renal fibrosis. BioMed Research International. 2017; 2418671. https://doi.org/10.1155/2017/2418671. [crossref] [PubMed]
58.
Dibazar SP, Fateh S, Daneshmandi S. Clove (Syzygiumaromaticum) ingredients affect lymphocyte subtypes expansion and cytokine profile responses: An in vitro evaluation. J Food Drug Anal. 2014;22:448-454. [crossref] [PubMed]
59.
Niphade SR, Asad M, Chandrakala GK, Toppo E, Deshmukh P. Immunomodulatory activity of Cinnamomum zeylanicum Bark. Pharm Biol. 2009;47:1168-73. [crossref]
60.
Goel B, Mishra S. Medicinal and Nutritional Perspective of Cinnamon: A mini-review. European Journal of Medicinal Plants. 2020;31:10-16. [crossref]
61.
Valizadeh S, Katiraee F, Mahmoudi R, Fakheri T, Mardani K. Biological properties of Cinnamomum zeylanicum essential oil: Phytochemical component, antioxidant and antimicrobial activities. International Journal of Food Safety, Nutrition and Public Health. 2015;6:174-84.
62.
Tsui PF, Lin CS, Ho LJ, Lai JH. Spices and atherosclerosis. Nutrients. 2018.https://doi.org/10.3390/nu10111724. [crossref] [PubMed]
63.
Prasanth DSNBK, Murahari M, Chandramohan V, Panda SP, Atmakuri LR, Guntupalli C. In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J Biomol Struct Dyn. 2020;01-15. Doi: 10.1080/07391102.2020.1779129. [crossref] [PubMed]
64.
Patra JK, Das G, Bose S, Banerjee S, Vishnuprasad CN, del Pilar Rodriguez-Torres M, Shin HS. Star anise (Illicium verum): Chemical compounds, antiviral properties, and clinical relevance. Phytother Res. 2020;34:1248-67. [crossref] [PubMed]
65.
Upadhyay RK. Thermal-Aroma-Organic-Carbon-Fusion therapy: An open air conventional method for clearance of nasal air passage, trachea, lungs and immunity boosting against Influenza Virus. Intern J Zool Invest. 2020;6:71-93. [crossref]

DOI and Others

10.7860/JCDR/2021/49530.15245

Date of Submission: Mar 20, 2021
Date of Peer Review: May 18, 2021
Date of Acceptance: Jun 24, 2021
Date of Publishing: Aug 01, 2021

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? NA
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Mar 30, 2021
• Manual Googling: Jun 23, 2021
• iThenticate Software: Jul 31, 2021 (16%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com